Stockscreener 앱 받기
0.6548
1.36%
-0.009
시장 영업 전:
.64
-0.0148
-2.26%
전일 마감가:
$0.6638
열려 있는:
$0.66
하루 거래량:
307.45K
Relative Volume:
0.10
시가총액:
$9.14M
수익:
$294.20K
순이익/손실:
$-12.25M
주가수익비율:
-0.1297
EPS:
-5.05
순현금흐름:
$-10.77M
1주 성능:
+3.89%
1개월 성능:
+12.90%
6개월 성능:
+61.64%
1년 성능:
-65.45%
1일 변동 폭
$0.63
$0.70
1주일 범위
$0.62
$0.7353
52주 변동 폭
$0.2375
$2.10
애틀론 메디컬 Stock (AEMD) Company Profile
명칭
Aethlon Medical Inc
전화
619-941-0360
주소
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
AEMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
0.6548 | 9.14M | 294.20K | -12.25M | -10.77M | -5.05 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
애틀론 메디컬 주식(AEMD)의 최신 뉴스
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in December - Defense World
Biostage (OTCMKTS:BSTG) and Aethlon Medical (NASDAQ:AEMD) Head to Head Review - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Head-To-Head Survey: Aethlon Medical (NASDAQ:AEMD) & West Pharmaceutical Services (NYSE:WST) - Defense World
Aethlon Medical receives extension to meet Nasdaq listing requirements - Investing.com
Aethlon Medical receives extension to meet Nasdaq listing requirements By Investing.com - Investing.com UK
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Co-Diagnostics (NASDAQ:CODX) and Aethlon Medical (NASDAQ:AEMD) Critical Review - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Large Growth in Short Interest - Defense World
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
Aethlon Medical (NASDAQ:AEMD) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World
Analyzing SeaStar Medical (NASDAQ:ICU) & Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu - PR Newswire
Aethlon Medical's Hemopurifier Shows 99% Bird Flu Virus Removal in Lab Tests Amid U.S. Outbreak - StockTitan
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Head-To-Head Analysis: AtriCure (NASDAQ:ATRC) and Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 42.1% in November - Defense World
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now - GlobeNewswire
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 22.7% in November - Defense World
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
HC Wainwright Reaffirms Buy Rating for Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2025 Earnings Call Transcript - Insider Monkey
Maxim retains hold on Aethlon Medical shares amid clinical progress By Investing.com - Investing.com UK
Aethlon Medical Advances Cancer Trial, Expands Hemopurifier Study Sites Globally | AEMD Stock News - StockTitan
Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ... - Yahoo Finance
Aethlon Medical Reports Progress in Oncology Trials - TipRanks
Aethlon Medical Advances Oncology Trials and Global Expansion - TipRanks
Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update - Kilgore News Herald
Aethlon Medical Launches Groundbreaking Cancer Trial for Hemopurifier Device in Australia | AEMD Stock News - StockTitan
AEMDAETHLON MEDICAL INC Latest Stock News & Market Updates - StockTitan
Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer - Medical Device Network
Aethlon Medical Launches Breakthrough Cancer Trial for Hemopurifier® Treatment | AEMD Stock News - StockTitan
Aethlon Medical (AEMD) Sets Q2 2024 Earnings Release for November 13 | AEMD Stock News - StockTitan
Finansavisen - Finansavisen
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now - The Manila Times
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, Interim CEO & CFO, and Steven LaRosa, MD, Chief Medical Officer, of Aethlon Medical Inc., with Marla Marin, Senior Analyst at Zacks SCR - Yahoo Finance
Is Aethlon Medical Inc (AEMD) worth investing in despite its overvalued state? - US Post News
Daily Progress: Aethlon Medical Inc (AEMD) Gain 1.15, Closing at 0.40 - The Dwinnex
Aethlon Medical Inc (AEMD) Q1 2025 Earnings Call Highlights: Strategic Cost Management and ... - Yahoo Finance
Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit - cnhinews.com
A new trading data show Aethlon Medical Inc (AEMD) is showing positive returns. - SETE News
Deeper Dive: Understanding Aethlon Medical Inc (AEMD) Through its Various Ratios - The Dwinnex
Aethlon Medical names James Frakes permanent CEO By Investing.com - Investing.com Canada
Aethlon Medical names James Frakes permanent CEO - Investing.com
애틀론 메디컬 (AEMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.55%
자본화:
|
볼륨(24시간):